| Application no. and date | 00914425.4 (espacenet) (Federated) (European Patent Register), 20000114 | | Patent/reg. no. and date | DK/EP 1140145, 20050706 | | Publication date | 20011010 | | Priority no. and date | US 116380 P, 19990114, US 175365 P, 20000110 | | EP pub. no. and date |
EP 1140145 20011010 | | Effective date | | | Applicant/owner | Amylin Pharmaceuticals, LLC, 9360 Towne Centre Drive
San Diego, CA 92121, US,
AstraZeneca Pharmaceuticals LP, 1800 Concord Pike
Wilmington, DE 19850-5437, US | | Applicant ref. no. | P200500710EPDK | | Inventor | KOLTERMAN, Orville, 15793 Hidden Valley Drive
Poway, CA 92064, US,
YOUNG, Andrew, P.O. Box 60591
Point Loma, CA 92166, US,
L'ITALIEN, James, J., 15752 Caminito Canteras
Del Mar, CA 92014, US | | Representative | Zacco Denmark A/S, Arne Jacobsens Allé 15, 2300 København S | | Opponent | | | IPC Class | A61K 38/22 (2006.01) , A61K 9/08 (2006.01) , A61K 9/19 (2006.01) , A61P 3/10 (2006.01) , A61P 5/50 (2006.01) , C07K 14/575 (2006.01) | | Title | Hidtil ukendte exendinagonistformuleringer og fremgangsmåder til indgivelse deraf | | Int. application no. | US2000000902 | | Int. publication no. | WO2000041546 | | Related patent (certificate) | CA 2007 00033 | | Status | Udløbet | | Pædiatrisk forlængelse | - | | Udløbsdato for pædiatrisk forlængelse | - |
|
